BioCentury | Apr 11, 2020
Emerging Company Profile

Clover: trimerizing fusion proteins

...Funds raised: Over $110 million Investors: Tianhe Life Sciences Venture Fund, Delos Capital, Lapam Capital, Betta Capital...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...$100 million since 2016. Delos Capital and Lapam Capital led the round, with participation by Betta Capital...
Items per page:
1 - 2 of 2
BioCentury | Apr 11, 2020
Emerging Company Profile

Clover: trimerizing fusion proteins

...Funds raised: Over $110 million Investors: Tianhe Life Sciences Venture Fund, Delos Capital, Lapam Capital, Betta Capital...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...$100 million since 2016. Delos Capital and Lapam Capital led the round, with participation by Betta Capital...
Items per page:
1 - 2 of 2